Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153930 · ClinicalTrials.gov registry record · NA
Sedentary Behavior and Health Outcomes Study
A NA study of Physical Activity and Pediatric Obesity, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03153930: Completed NA study of Physical Activity and Pediatric Obesity, sponsored by University of Southern California.
NCT03153930 is a NA study of Physical Activity and Pediatric Obesity that has completed, run by University of Southern California. The registered enrollment target is 35 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03153930, a NA study of Physical Activity and Pediatric Obesity, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized crossover trial to compare the effectiveness of interrupting SB on glucose homeostasis in the lab and free-living settings. All participants (N=56) will complete one screening visit to determine eligibility, complete at fitness test, and body composition analysis by bioelectrical impedance. After 7-21 days, all participants will complete two 3-hour in-lab oral glucose tolerance tests (spaced 7-21 days apart). Prior to the in-lab OGTT visits, participants will wear an activity monitor for 7 days on the right thigh. The experimental conditions for the OGTTs will be: 1) 3-hour OGTT of continuous sitting; and 2) 3-hour OGTT with sitting interrupted every 30 minutes with 3-minutes of moderate intensity walking on a treadmill. There will be a 7-21 day washout period between the OGTT visits. In addition, a subset of participants (N=12) who meet inclusion criteria and who successfully complete both OGTT visits will complete a second randomized crossover trial in the free-living environment. The experimental conditions for the free-living components will be: 1) 4 days of habitual sedentary behaviors; and 2) 4 days of prompted short exercise breaks during times in which sedentary behaviors have exceeded 30 minutes. Participants in the free-living trial will wear an activity monitor and a continuous glucose monitor.
Primary Outcome
glucose, insulin, and c-peptide area under the curve
Conditions Studied
Interventions
- BEHAVIORAL Walking breaks
- BEHAVIORAL Sitting only
Study Locations (1)
California
- University of Southern California Keck School of Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03153930 record still lists
NCT03153930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (90% lower).
The record links to 4 conditions, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which Walking breaks is the first listed.
NCT03153930 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03153930 about?
NCT03153930 is a clinical study titled "Sedentary Behavior and Health Outcomes Study". This study is a randomized crossover trial to compare the effectiveness of interrupting SB on glucose homeostasis in the lab and free-living settings. All participants (N=56) will complete one screening visit to determine eligibility, complete at fitness test, and body composition analysis by bioele...
What is the current status of trial NCT03153930?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-01-01. Estimated completion is 2020-06-30.
What conditions does trial NCT03153930 study?
This clinical trial studies the following conditions: Physical Activity, Pediatric Obesity, Sedentary Lifestyle, Metabolic Disturbance.
What interventions are being tested in trial NCT03153930?
The interventions under investigation include: Walking breaks (BEHAVIORAL), Sitting only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03153930?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03153930 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03153930's enrollment target sits among peer trials
35 111th of 131 higher than 20 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI